Israel Discount Bank of New York’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,980
| Closed | -$621K | – | 83 |
|
|
2020
Q4 | $621K | Sell |
3,980
-2,157
| -35% | -$337K | 0.45% | 51 |
|
|
2020
Q3 | $703K | Sell |
6,137
-282
| -4% | -$32.3K | 0.46% | 55 |
|
|
2020
Q2 | $721K | Sell |
6,419
-1,245
| -16% | -$140K | 0.49% | 50 |
|
|
2020
Q1 | $688K | Buy |
7,664
+747
| +11% | +$67.1K | 0.53% | 52 |
|
|
2019
Q4 | $748K | Buy |
6,917
+110
| +2% | +$11.9K | 0.49% | 54 |
|
|
2019
Q3 | $667K | Buy |
6,807
+908
| +15% | +$89K | 0.49% | 56 |
|
|
2019
Q2 | $773K | Buy |
5,899
+215
| +4% | +$28.2K | 0.59% | 43 |
|
|
2019
Q1 | $769K | Buy |
5,684
+234
| +4% | +$31.7K | 0.53% | 38 |
|
|
2018
Q4 | $531K | Buy |
5,450
+135
| +3% | +$13.2K | 0.41% | 50 |
|
|
2018
Q3 | $739K | Buy |
5,315
+300
| +6% | +$41.7K | 0.48% | 40 |
|
|
2018
Q2 | $622K | Buy |
5,015
+612
| +14% | +$75.9K | 0.41% | 50 |
|
|
2018
Q1 | $491K | Buy |
4,403
+689
| +19% | +$76.8K | 0.33% | 61 |
|
|
2017
Q4 | $444K | Buy |
3,714
+885
| +31% | +$106K | 0.31% | 67 |
|
|
2017
Q3 | $397K | Buy |
2,829
+240
| +9% | +$33.7K | 0.3% | 68 |
|
|
2017
Q2 | $315K | Buy |
2,589
+2,400
| +1,270% | +$292K | 0.25% | 73 |
|
|
2017
Q1 | $23K | Sell |
189
-10
| -5% | -$1.22K | 0.02% | 363 |
|
|
2016
Q4 | $24K | Buy |
+199
| New | +$24K | 0.02% | 390 |
|